A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/16/2011	EP2386311A1 Compositions for improving lipid metabolism
11/16/2011	EP2386310A2 Methods for preserving organs and tissues
11/16/2011	EP2385954A1 Complex and production process
11/16/2011	EP2385843A1 Treatment of mucositis with kallikrein inhibitors
11/16/2011	EP2385841A1 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
11/16/2011	EP2385840A1 Materials and methods for the treatment of hypertension
11/16/2011	EP2385839A2 Therapeutic compositions for treatment of corneal disorders
11/16/2011	EP2385838A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection
11/16/2011	EP2385833A1 Combination of a cyclosporine derivative and nucleosides for treating hcv
11/16/2011	EP2385825A1 Factor viii formulations
11/16/2011	EP2297195B1 Antibacterial peptides
11/16/2011	EP2103630B1 Preparation of low bleeding anticoagulant fusion protein and its use
11/16/2011	EP2044952B1 Use of the pedf factor to induce cell regeneration
11/16/2011	EP1901768B1 Methods of modulating il-23 activity; related reagents
11/16/2011	EP1885751B1 Bone morphogenetic protein 6 containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
11/16/2011	EP1883649B1 Hiv vif mutants
11/16/2011	EP1765851B1 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
11/16/2011	EP1664089B1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	EP1455588B1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
11/16/2011	EP1019439B1 Soluble single-chain t-cell receptor proteins
11/16/2011	CN1930182B Antithrombotic compound
11/16/2011	CN1839203B FVII or FVIIa GLA domain variants
11/16/2011	CN1820018B Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
11/16/2011	CN102246045A Biomarkers and methods for detecting and treating spinal and joint pain
11/16/2011	CN102245642A Conjugates of GLP-1 agonists and uses thereof
11/16/2011	CN102245633A Novel insulin analogues
11/16/2011	CN102245632A Muc-1 cytoplasmic domain peptides as inhibitors of cancer
11/16/2011	CN102245630A Polypeptides having antimicrobial activity
11/16/2011	CN102245210A Octreotide depot formulation with constantly high exposure levels
11/16/2011	CN102245196A Na/K-ATPase-derived peptide SRC inhibitors and ouabain antagonists and uses thereof
11/16/2011	CN102245195A Biodefenses using triazole-containing macrolides
11/16/2011	CN102245185A Combination of insulin with triazine derivatives and its use for treating diabetes
11/16/2011	CN102242138A Recombination expression of cynoglossus semilaevis antibacterial peptide hepcidin and application thereof
11/16/2011	CN102242128A Scylla paramamosain antiviral type anti-lipopolysaccharide factor, its preparation method and application
11/16/2011	CN102242127A Preparation method of serial antibacterial peptide Alloferon-1 and application of rAlloferon-1-K
11/16/2011	CN102242124A Modified Keratinocyte growth factor gene and its expression in yeast
11/16/2011	CN102242120A Modified human vascular eNOS (Endothelial Nitric Oxide Synthase) gene promoter and preparation method and application thereof
11/16/2011	CN102241777A Targeted PTEN gene composite, and preparation method and application thereof
11/16/2011	CN102241759A Bacteriostatic ferritin and preparation and application thereof
11/16/2011	CN102241756A High expression of tenebrio molitor antibacterial peptide TmAMP3m in escherichia coli and application of TmAMP3m
11/16/2011	CN102241751A Novel fungal immunomodulatory protein FIP-NHA with antineoplastic activity and gene thereof
11/16/2011	CN102241748A Mycobacterium phage D29 derived PK34 polypeptide and application thereof
11/16/2011	CN102241745A Polypeptide analog Tat-HA-NR2B9C, and preparation method and application thereof
11/16/2011	CN102241744A Virus infection blocker, and its drug composition and application
11/16/2011	CN102241742A Peptides and compounds that bind to a thrombopoietin receptor
11/16/2011	CN102241740A Compounds with thrombolytic activities and preparation methods and applications thereof
11/16/2011	CN102241737A Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines
11/16/2011	CN102241735A Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof
11/16/2011	CN102241734A Anticoagulation polypeptide and application thereof
11/16/2011	CN102241733A Deer ossein polypeptide chelated calcium and enteric capsule and preparation method of enteric capsule
11/16/2011	CN102241674A Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester
11/16/2011	CN102240397A Production of high mannose proteins in plant culture
11/16/2011	CN102240396A Application of multienzyme compound to prevention and treatment of fungus infection
11/16/2011	CN102240395A Application of interleukin-1 acceptor antagonist
11/16/2011	CN102240394A Use of interleukin-1receptor antagonist (IL-1Ra), and pharmaceutical compositions of IL-1Ra
11/16/2011	CN102240393A Injection preparation containing argatroban
11/16/2011	CN102240300A Method for producing biologically active products
11/16/2011	CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
11/16/2011	CN102240037A Amino acid and calcium composite powder
11/16/2011	CN102240034A Combination with functions of increasing bone density and preventing osteoporosis
11/16/2011	CN102068488B Traditional Chinese medicinal composition and preparation method for granules thereof
11/16/2011	CN101891802B Polypeptide or derivative product for treating or preventing cancer and application thereof
11/16/2011	CN101838310B Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
11/16/2011	CN101822694B Preparation of dry powder water soluble extract of ground beetle and application thereof in medicine
11/16/2011	CN101659700B Short peptide
11/16/2011	CN101649312B Human plasminogen K5 modified by RGD and preparation method and application thereof
11/16/2011	CN101638435B Blue-green algal virus protein N mutant, modified derivative and application thereof
11/16/2011	CN101628931B Antitumor antibiotics, pharmaceutically acceptable salts thereof, preparation method thereof and use thereof
11/16/2011	CN101461934B Application of small-molecule peptide in preparing medicament and food for promoting wound healing after operation
11/16/2011	CN101407812B Heterologous expression and purification method for human RANTES protein having chemotaxis
11/16/2011	CN101343313B Glucose dipeptide compounds, preparation method and application thereof
11/16/2011	CN101302245B Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/16/2011	CN101121753B Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell
11/16/2011	CN101095942B Formulation of the Exendin injection medicine containing stabilizing agent
11/15/2011	US8058483 Phi/phi form; stabilizing such as vitamin C; shelf life
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058401 Immunogenic compositions and uses thereof
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058396 Cystatin C as an antagonist of TGF-β and methods related thereto
11/15/2011	US8058393 Microwave-assisted peptide synthesis
11/15/2011	US8058392 Carbon nanotube binding peptides
11/15/2011	US8058391 Process for the preparation of insulin conjugate IN-105
11/15/2011	US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011	US8058256 Polymeric carrier for delivery of small interfering RNA
11/15/2011	US8058254 DNA vaccines encoding heat shock proteins
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058244 Cyclic peptide antitumor agents
11/15/2011	US8058242 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule
11/15/2011	US8058241 Signal transduction protein TAB2
11/15/2011	US8058240 Biological active ligands of melanocortin receptors
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058238 High purity lipopeptides
11/15/2011	US8058237 Stable composition of GDF-5 and method of storage
11/15/2011	US8058236 Aqueous inhalation pharmaceutical composition

1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 3163